Treatment of pulmonary arterial hypertension (PAH): Updated Recommendations of the Cologne Consensus Conference 2011-Reference-Cited by-同舟云学术

Treatment of pulmonary arterial hypertension (PAH): Updated Recommendations of the Cologne Consensus Conference 2011

Published:2011-12 Issue: Volume:154 Page:S20-S33
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Ghofrani H. Ardeschir,Distler Oliver,Gerhardt Felix,Gorenflo Matthias,Grünig Ekkehard,Haefeli Walter E.,Held Matthias,Hoeper Marius M.,Kähler Christian M.,Kaemmerer Harald,Klose Hans,Köllner Volker,Kopp Bruno,Mebus Siegrun,Meyer Andreas,Miera Oliver,Pittrow David,Riemekasten Gabriela,Rosenkranz Stephan,Schranz Dietmar,Voswinckel Robert,Olschewski Horst

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference67 articles.

1. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

2. Guidelines for the diagnosis and treatment of pulmonary hypertension

3. Diagnostik und Therapie der pulmonalen Hypertonie: Europäische Leitlinien 2009;Hoeper;Pneumologie,2010

4. A meta-analysis of randomized controlled trials in pulmonary arterial hypertension;Galie;Eur Heart J,2009

5. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension;Mereles;Circulation,2006

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No genetic causal association between iron status and pulmonary artery hypertension: Insights from a two‐sample Mendelian randomization;Pulmonary Circulation;2024-04

2. Efficacy and safety of macitentan for pulmonary hypertension: A meta‐analysis;The Clinical Respiratory Journal;2023-07-10

3. Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis;Journal of Health Economics and Outcomes Research;2022-06-08

4. Comparison of Healthcare Encounters and Drug Persistence in Patients With Pulmonary Arterial Hypertension Receiving Oral Selexipag, Inhaled Iloprost, or Parenteral Treprostinil: A Retrospective Database Analysis;Journal of Health Economics and Outcomes Research;2022-06-08

5. Diffuse myocardial fibrosis precedes subclinical functional myocardial impairment and provides prognostic information in systemic sclerosis;European Heart Journal - Cardiovascular Imaging;2022-05-26